Sept 17 (Reuters) - Vectus Biosystems Ltd VBS.AX :
* ANNOUNCES A SUCCESSFUL CONVERTIBLE NOTE ISSUE TO RAISE AN AMOUNT OF $7 MILLION
* FUNDS WILL BE USED TO COMPLETE PHASE I CLINICAL TRIALS FOR VB0004, WHICH POTENTIALLY PREVENTS & REVERSES FIBROSIS IN ORGANS